Barclays Boosts HealthStream (NASDAQ:HSTM) Price Target to $34.00

HealthStream (NASDAQ:HSTM) had its price target hoisted by Barclays from $32.00 to $34.00 in a report released on Wednesday morning, Benzinga reports. Barclays currently has an overweight rating on the technology company’s stock.

A number of other research firms have also recently issued reports on HSTM. Craig Hallum upgraded HealthStream to a “strong-buy” rating in a research note on Thursday, October 17th. Canaccord Genuity Group boosted their target price on shares of HealthStream from $27.00 to $28.00 and gave the company a “hold” rating in a research note on Wednesday, July 24th. Finally, StockNews.com lowered shares of HealthStream from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 24th. Two research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $31.50.

HealthStream Stock Performance

HSTM stock opened at $28.31 on Wednesday. HealthStream has a 1 year low of $23.92 and a 1 year high of $31.15. The firm has a market cap of $860.91 million, a P/E ratio of 43.55, a price-to-earnings-growth ratio of 4.45 and a beta of 0.36. The stock has a 50-day simple moving average of $28.72 and a 200-day simple moving average of $27.91.

HealthStream (NASDAQ:HSTM) last released its earnings results on Monday, October 21st. The technology company reported $0.19 earnings per share for the quarter, beating the consensus estimate of $0.13 by $0.06. The firm had revenue of $73.10 million during the quarter, compared to analyst estimates of $73.53 million. HealthStream had a net margin of 6.84% and a return on equity of 5.67%. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.13 earnings per share. On average, equities research analysts predict that HealthStream will post 0.56 EPS for the current year.

HealthStream Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be paid a dividend of $0.028 per share. This represents a $0.11 dividend on an annualized basis and a yield of 0.40%. The ex-dividend date of this dividend is Monday, November 4th. HealthStream’s payout ratio is 16.92%.

Insiders Place Their Bets

In other HealthStream news, Director Tate Deborah Taylor sold 1,400 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the sale, the director now directly owns 22,326 shares in the company, valued at $636,960.78. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other HealthStream news, Director Tate Deborah Taylor sold 1,400 shares of the company’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the sale, the director now directly owns 22,326 shares in the company, valued at $636,960.78. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Kevin P. O’hara sold 3,000 shares of the stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $28.03, for a total value of $84,090.00. Following the sale, the senior vice president now owns 9,527 shares of the company’s stock, valued at $267,041.81. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 20.60% of the stock is currently owned by insiders.

Institutional Trading of HealthStream

Several large investors have recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its stake in shares of HealthStream by 172.1% in the second quarter. GAMMA Investing LLC now owns 996 shares of the technology company’s stock worth $28,000 after acquiring an additional 630 shares during the last quarter. Point72 DIFC Ltd acquired a new position in HealthStream during the second quarter worth $38,000. Copeland Capital Management LLC acquired a new position in HealthStream during the third quarter worth $63,000. CWM LLC increased its position in HealthStream by 405.4% during the second quarter. CWM LLC now owns 2,709 shares of the technology company’s stock worth $76,000 after buying an additional 2,173 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in HealthStream during the second quarter worth $214,000. 69.58% of the stock is owned by institutional investors and hedge funds.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.